Antenatal dexamethasone and the growth hormone–insulin-like growth factor axis
Open Access
- 1 June 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 15 (6), 1403-1406
- https://doi.org/10.1093/humrep/15.6.1403
Abstract
Dexamethasone administration has marked effects on the growth hormone-insulin-like growth factor axis (GH–IGF) in animal and human studies. During pregnancy in the rat, it is associated with fetal growth restriction due to inhibition of IGF bioactivity. In the human only repeated dosages have been associated with fetal growth restriction. The aim of this study is to test the hypothesis that antenatal dexamethasone administration to pregnant women is associated with reduced activity of the GH–IGF axis. To achieve this blood samples were taken from 12 pregnant women pre- and at 24 h and 48 h after dexamethasone administration. In these samples GH, IGF-I, IGF bioactivity and IGF binding protein (IGFBP)-3 protease activity were measured. In view of the interaction between insulin and the GH–IGF axis, glucose and insulin concentrations were also measured. There were no significant differences between the concentrations of GH, IGF-I, IGF bioactivity and IGFBP-3 protease activity before and after dexamethasone. The concentrations of glucose and insulin were significantly higher at 24 h, but not 48 h post-dexamethasone. It is concluded that a single antenatal course of dexamethasone does not alter the GH–IGF-I axis in pregnant women at the time points studied.Keywords
This publication has 19 references indexed in Scilit:
- Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring.JCI Insight, 1998
- Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.JCI Insight, 1997
- A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.Endocrinology, 1996
- Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994American Journal of Obstetrics and Gynecology, 1995
- The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteersJournal of Endocrinology, 1993
- Acute Administration of Corticoids: A New and Peculiar Stimulus of Growth Hormone Secretion in Man*Journal of Clinical Endocrinology & Metabolism, 1990
- Dose-Response Characteristics for Suppression of Low Molecular Weight Plasma Insulin-Like Growth Factor-Binding Protein by Insulin*Journal of Clinical Endocrinology & Metabolism, 1989
- ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN?Clinical Endocrinology, 1988
- Somatomedin C/insulin-like growth factor I: simplified purification procedure and biological activities of the purified growth factorJournal of Endocrinology, 1986
- EFFECT OF CORTICOSTEROIDS ON SERUM GROWTH HORMONEThe Lancet, 1964